Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation

Mise à jour : Il y a 6 ans
Référence : NCT01058434

Femme et Homme

Extrait

This study will evaluate safety and efficacy of TKI258 in patients with relapsed or refractory multiple myeloma


Critère d'inclusion

  • Relapsed or Refractory Multiple Myeloma


Liens